Pharmaceutical markets in North Africa, the Levant states and Iran as well as the GCC countries (Saudi Arabia, Kuwait, Bahrain, Oman, Qatar and the UAE) have a combined value of over SR44 billion ($12 billion) and are estimated to be growing at an annual rate of over 10 percent. In the Middle East, there is an estimated over 450 pharmaceutical manufacturers - a figure that is growing dramatically year on year. “This is a market that the Freezone is keen to attract,” said Ibrahim Ahli, marketing director Dubai Airport Free Zone, said. Dubai Airport Free Zone, home to multinational pharmaceutical companies in the UAE, took part in the largest three-day pharmaceutical and biotechnology event (Pharmaceutical & Biotechnology Middle East) PABME 2009 at Dubai International Convention and Exhibition Center which ended on Wednesday. Dubai Airport Free Zone has been participating in quite a number of specialised exhibitions which help the free zone attract multinational companies. “The pharmaceutical and biotechnology sectors are growing at such an incredible rate in the region,” he added. __